Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:13-27
© 2001 American Heart Association, Inc.
Brief Reviews |
High Density Lipoproteins and Arteriosclerosis
Role of Cholesterol Efflux and Reverse Cholesterol Transport
From the Institut für Klinische Chemie und Laboratoriumsmedizin (A.v.E., J.-R.N., G.A.), Zentrallaboratorium, Westfälische Wilhelms-Universität Münster, and the Institut für Arterioskleroseforschung an der Universität Münster (A.v.E., J.-R.N., G.A.), Münster, Germany.
Correspondence to Dr Arnold von Eckardstein, Institut für Klinische Chemie und Laboratoriumsmedizin, Zentrallaboratorium, Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Strasse 33, D-48129 Münster, Germany. E-mail vonecka{at}uni-muenster.de
Abstract—High density lipoprotein (HDL) cholesterol is an important risk factor for coronary heart disease, and HDL exerts various potentially antiatherogenic properties, including the mediation of reverse transport of cholesterol from cells of the arterial wall to the liver and steroidogenic organs. Enhancement of cholesterol efflux and of reverse cholesterol transport (RCT) is considered an important target for antiatherosclerotic drug therapy. Levels and composition of HDL subclasses in plasma are regulated by many factors, including apolipoproteins, lipolytic enzymes, lipid transfer proteins, receptors, and cellular transporters. In vitro experiments as well as genetic family and population studies and investigation of transgenic animal models have revealed that HDL cholesterol plasma levels do not necessarily reflect the efficacy and antiatherogenicity of RCT. Instead, the concentration of HDL subclasses, the mobilization of cellular lipids for efflux, and the kinetics of HDL metabolism are important determinants of RCT and the risk of atherosclerosis.
Key Words: apolipoproteins • lipid transfer proteins • lipases • ABC transporter • Tangier disease
This article has been cited by other articles:
 |
|
 |
|
  Y. Qin, M. Xia, J. Ma, Y. Hao, J. Liu, H. Mou, L. Cao, and W. Ling Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects Am. J. Clinical Nutrition, September 1, 2009; 90(3): 485 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wiersma, A. Gatti, N. Nijstad, F. Kuipers, and U. J. F. Tietge Hepatic SR-BI, not endothelial lipase, expression determines biliary cholesterol secretion in mice J. Lipid Res., August 1, 2009; 50(8): 1571 - 1580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. R. Superko Advanced Lipoprotein Testing and Subfractionation Are Clinically Useful Circulation, May 5, 2009; 119(17): 2383 - 2395. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Y. Tsai, N. Li, A. R. Sharrett, S. Shea, D. R. Jacobs Jr, R. Tracy, D. Arnett, V. Arends, and W. Post Associations of Genetic Variants in ATP-Binding Cassette A1 and Cholesteryl Ester Transfer Protein and Differences in Lipoprotein Subclasses in the Multi-Ethnic Study of Atherosclerosis Clin. Chem., March 1, 2009; 55(3): 481 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Catalano, Z. Julia, E. Frisdal, B. Vedie, N. Fournier, W. Le Goff, M. J. Chapman, and M. Guerin Torcetrapib Differentially Modulates the Biological Activities of HDL2 and HDL3 Particles in the Reverse Cholesterol Transport Pathway Arterioscler Thromb Vasc Biol, February 1, 2009; 29(2): 268 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M. Heid, E. Boes, M. Muller, B. Kollerits, C. Lamina, S. Coassin, C. Gieger, A. Doring, N. Klopp, R. Frikke-Schmidt, et al. Genome-Wide Association Analysis of High-Density Lipoprotein Cholesterol in the Population-Based KORA Study Sheds New Light on Intergenic Regions Circ Cardiovasc Genet, October 1, 2008; 1(1): 10 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Hime, A. S. Black, J. J. Bulgrien, and L. K. Curtiss Leukocyte-derived hepatic lipase increases HDL and decreases en face aortic atherosclerosis in LDLr-/- mice expressing CETP J. Lipid Res., October 1, 2008; 49(10): 2113 - 2123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ahnstrom, O. Axler, M. Jauhiainen, V. Salomaa, A. S. Havulinna, C. Ehnholm, R. Frikke-Schmidt, A. Tybjaerg-Hansen, and B. Dahlback Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies J. Lipid Res., September 1, 2008; 49(9): 1912 - 1917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Guha, D. L. Gantz, and O. Gursky Effects of acyl chain length, unsaturation, and pH on thermal stability of model discoidal HDLs J. Lipid Res., August 1, 2008; 49(8): 1752 - 1761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Wool, C. A. Reardon, and G. S. Getz Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties J. Lipid Res., June 1, 2008; 49(6): 1268 - 1283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ray, C. M. Herring, T. A. Markel, P. R. Crisostomo, M. Wang, B. Weil, T. Lahm, and D. R. Meldrum Deleterious effects of endogenous and exogenous testosterone on mesenchymal stem cell VEGF production Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1498 - R1503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Catalano, E. Duchene, Z. Julia, W. Le Goff, E. Bruckert, M. J. Chapman, and M. Guerin Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects J. Lipid Res., March 1, 2008; 49(3): 635 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhou, K. C. Tan, S. W. Shiu, and Y. Wong Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathy Nephrol. Dial. Transplant., March 1, 2008; 23(3): 927 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Superko and S. King III Lipid Management to Reduce Cardiovascular Risk: A New Strategy Is Required Circulation, January 29, 2008; 117(4): 560 - 568. [Full Text] [PDF]
|
|
|
|
 |
|
 R. P F Dullaart, A. K Groen, G. M Dallinga-Thie, R. de Vries, W. J Sluiter, and A. van Tol Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol Eur. J. Endocrinol., January 1, 2008; 158(1): 53 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Adorni, F. Zimetti, J. T. Billheimer, N. Wang, D. J. Rader, M. C. Phillips, and G. H. Rothblat The roles of different pathways in the release of cholesterol from macrophages J. Lipid Res., November 1, 2007; 48(11): 2453 - 2462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Van Eck, M. Hoekstra, R. B. Hildebrand, Y. Yaong, D. Stengel, J. K. Kruijt, W. Sattler, U. J.F. Tietge, E. Ninio, T. J.C. Van Berkel, et al. Increased Oxidative Stress in Scavenger Receptor BI Knockout Mice With Dysfunctional HDL Arterioscler Thromb Vasc Biol, November 1, 2007; 27(11): 2413 - 2419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kajaia, H. Binder, R. Dittrich, P. G Oppelt, B. Flor, S. Cupisti, M. W Beckmann, and A. Mueller Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome Eur. J. Endocrinol., October 1, 2007; 157(4): 499 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Ng, N. Bourquard, S. Y. Hama, D. Shih, V. R. Grijalva, M. Navab, A. M. Fogelman, and S. T. Reddy Adenovirus-Mediated Expression of Human Paraoxonase 3 Protects Against the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1368 - 1374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Tardif, J. Gregoire, P. L. L'Allier, R. Ibrahim, J. Lesperance, T. M. Heinonen, S. Kouz, C. Berry, R. Basser, M.-A. Lavoie, et al. Effects of Reconstituted High-Density Lipoprotein Infusions on Coronary Atherosclerosis: A Randomized Controlled Trial JAMA, April 18, 2007; 297(15): 1675 - 1682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Ng, N. Bourquard, V. Grijalva, S. Hama, D. M. Shih, M. Navab, A. M. Fogelman, A. J. Lusis, S. Young, and S. T. Reddy Paraoxonase-2 Deficiency Aggravates Atherosclerosis in Mice Despite Lower Apolipoprotein-B-containing Lipoproteins: ANTI-ATHEROGENIC ROLE FOR PARAOXONASE-2 J. Biol. Chem., October 6, 2006; 281(40): 29491 - 29500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kontush and M. J. Chapman Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis Pharmacol. Rev., September 1, 2006; 58(3): 342 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M J. Chapman The effects of fibrates on lipid metabolism and inflammation in type 2 diabetes Diabetes and Vascular Disease Research, September 1, 2006; 3(1_suppl): S6 - S9. [Abstract] [PDF]
|
|
|
|
|
|
K. L.E. Klos, C. F. Sing, E. Boerwinkle, S. C. Hamon, T. J. Rea, A. Clark, M. Fornage, and J. E. Hixson Consistent Effects of Genes Involved in Reverse Cholesterol Transport on Plasma Lipid and Apolipoprotein Levels in CARDIA Participants Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1828 - 1836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. T. Duong, H. L. Collins, M. Nickel, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips Characterization of nascent HDL particles and microparticles formed by ABCA1-mediated efflux of cellular lipids to apoA-I J. Lipid Res., April 1, 2006; 47(4): 832 - 843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Yesilaltay, M. G. Morales, L. Amigo, S. Zanlungo, A. Rigotti, S. L. Karackattu, M. H. Donahee, K. F. Kozarsky, and M. Krieger Effects of Hepatic Expression of the High-Density Lipoprotein Receptor SR-BI on Lipoprotein Metabolism and Female Fertility Endocrinology, April 1, 2006; 147(4): 1577 - 1588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Van Eck, R. R. Singaraja, D. Ye, R. B. Hildebrand, E. R. James, M. R. Hayden, and T. J.C. Van Berkel Macrophage ATP-Binding Cassette Transporter A1 Overexpression Inhibits Atherosclerotic Lesion Progression in Low-Density Lipoprotein Receptor Knockout Mice Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 929 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ji, G. F. Watts, A. G. Johnson, D. C. Chan, E. M. M. Ooi, K.-A. Rye, A. P. Serone, and P. H. R. Barrett High-Density Lipoprotein (HDL) Transport in the Metabolic Syndrome: Application of a New Model for HDL Particle Kinetics J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 973 - 979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Heeren, U. Beisiegel, and T. Grewal Apolipoprotein E Recycling: Implications for Dyslipidemia and Atherosclerosis Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 442 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ohashi, H. Mu, X. Wang, Q. Yao, and C. Chen Reverse cholesterol transport and cholesterol efflux in atherosclerosis QJM, December 1, 2005; 98(12): 845 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. L. Ruel, B. Lamarche, J.-F. Mauger, K. O. Badellino, J. S. Cohn, M. Marcil, and P. Couture Effect of Fenofibrate on Plasma Lipoprotein Composition and Kinetics in Patients With Complete Hepatic Lipase Deficiency Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2600 - 2607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Rigamonti, L. Helin, S. Lestavel, A.L. Mutka, M. Lepore, C. Fontaine, M.A. Bouhlel, S. Bultel, J.C. Fruchart, E. Ikonen, et al. Liver X Receptor Activation Controls Intracellular Cholesterol Trafficking and Esterification in Human Macrophages Circ. Res., September 30, 2005; 97(7): 682 - 689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ragozin, A. Niemeier, A. Laatsch, B. Loeffler, M. Merkel, U. Beisiegel, and J. Heeren Knockdown of Hepatic ABCA1 by RNA Interference Decreases Plasma HDL Cholesterol Levels and Influences Postprandial Lipemia in Mice Arterioscler Thromb Vasc Biol, July 1, 2005; 25(7): 1433 - 1438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Argmann, J. Y. Edwards, C. G. Sawyez, C. H. O'Neil, R. A. Hegele, J. G. Pickering, and M. W. Huff Regulation of Macrophage Cholesterol Efflux through Hydroxymethylglutaryl-CoA Reductase Inhibition: A ROLE FOR RhoA IN ABCA1-MEDIATED CHOLESTEROL EFFLUX J. Biol. Chem., June 10, 2005; 280(23): 22212 - 22221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Papadopoulos Cholesterol Homeostasis and Infertility: The Liver X Receptor Connection Endocrinology, June 1, 2005; 146(6): 2517 - 2518. [Full Text] [PDF]
|
|
|
|
|
|
W. Khovidhunkit, J. P. Hachem, K. F. Medzihradszky, P. N. Duchateau, J. K. Shigenaga, A. H. Moser, I. Movsesyan, J. Naya-Vigne, J. P. Kane, K. R. Feingold, et al. Parotid secretory protein is an HDL-associated protein with anticandidal activity Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1306 - R1315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Drury and V. Narayanaswami Examination of Lipid-bound Conformation of Apolipoprotein E4 by Pyrene Excimer Fluorescence J. Biol. Chem., April 15, 2005; 280(15): 14605 - 14610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Brundert, A. Ewert, J. Heeren, B. Behrendt, R. Ramakrishnan, H. Greten, M. Merkel, and F. Rinninger Scavenger Receptor Class B Type I Mediates the Selective Uptake of High-Density Lipoprotein-Associated Cholesteryl Ester by the Liver in Mice Arterioscler Thromb Vasc Biol, January 1, 2005; 25(1): 143 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Heeren, T. Grewal, A. Laatsch, N. Becker, F. Rinninger, K.-A. Rye, and U. Beisiegel Impaired Recycling of Apolipoprotein E4 Is Associated with Intracellular Cholesterol Accumulation J. Biol. Chem., December 31, 2004; 279(53): 55483 - 55492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Out, M. Hoekstra, J. A. A. Spijkers, J. K. Kruijt, M. van Eck, I. S. T. Bos, J. Twisk, and T. J. C. Van Berkel Scavenger receptor class B type I is solely responsible for the selective uptake of cholesteryl esters from HDL by the liver and the adrenals in mice J. Lipid Res., November 1, 2004; 45(11): 2088 - 2095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. de Grooth, A. H. E. M. Klerkx, E. S. G. Stroes, A. F. H. Stalenhoef, J. J. P. Kastelein, and J. A. Kuivenhoven A review of CETP and its relation to atherosclerosis J. Lipid Res., November 1, 2004; 45(11): 1967 - 1974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kaul, B. Coin, A. Hedayiti, J. Yano, B. Cercek, K.-Y. Chyu, and P. K. Shah Rapid reversal of endothelial dysfunction in hypercholesterolemic apolipoprotein E-null mice by recombinant apolipoprotein A-IMilano-phospholipid complex J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1311 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Yancey, B. F. Asztalos, N. Stettler, D. Piccoli, D. L. Williams, M. A. Connelly, and G. H. Rothblat SR-BI- and ABCA1-mediated cholesterol efflux to serum from patients with Alagille syndrome J. Lipid Res., September 1, 2004; 45(9): 1724 - 1732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Khovidhunkit, M.-S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host J. Lipid Res., July 1, 2004; 45(7): 1169 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Faber, O. Axler, B. Dahlback, and L. B. Nielsen Characterization of apoM in normal and genetically modified mice J. Lipid Res., July 1, 2004; 45(7): 1272 - 1278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.J. Chapman Are the effects of statins on HDL-cholesterol clinically relevant? Eur. Heart J. Suppl., July 1, 2004; 6(suppl_C): C58 - C63. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Assmann and A. M. Gotto Jr HDL Cholesterol and Protective Factors in Atherosclerosis Circulation, June 15, 2004; 109(23_suppl_1): III-8 - III-14. [Abstract] [Full Text]
|
|
|
|
|
|
M. D. Brown, L. Jin, M.-L. Jien, A. H. Matsumoto, G. A. Helm, A. J. Lusis, J. S. Frank, and W. Shi Lipid retention in the arterial wall of two mouse strains with different atherosclerosis susceptibility J. Lipid Res., June 1, 2004; 45(6): 1155 - 1161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Walter, N. R. Forsyth, W. E. Wright, J. W. Shay, and M. G. Roth The Establishment of Telomerase-immortalized Tangier Disease Cell Lines Indicates the Existence of an Apolipoprotein A-I-inducible but ABCA1-independent Cholesterol Efflux Pathway J. Biol. Chem., May 14, 2004; 279(20): 20866 - 20873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F Watts Treating low HDL-cholesterol in normocholesterolaemic patients with coronary disease: statins, fibrates or horses for courses? Eur. Heart J., May 1, 2004; 25(9): 716 - 719. [Full Text] [PDF]
|
|
|
|
|
|
L. Krimbou, M. Denis, B. Haidar, M. Carrier, M. Marcil, and J. Genest Jr. Molecular interactions between apoE and ABCA1: impact on apoE lipidation J. Lipid Res., May 1, 2004; 45(5): 839 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Haidar, M. Denis, M. Marcil, L. Krimbou, and J. Genest Jr. Apolipoprotein A-I Activates Cellular cAMP Signaling through the ABCA1 Transporter J. Biol. Chem., March 12, 2004; 279(11): 9963 - 9969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hattori, T. Kujiraoka, T. Egashira, E. Saito, T. Fujioka, S. Takahashi, M. Ito, J. A. Cooper, I. P. Stepanova, M. N. Nanjee, et al. Association of Coronary Heart Disease with Pre-{beta}-HDL Concentrations in Japanese Men Clin. Chem., March 1, 2004; 50(3): 589 - 595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Pussinen, M. Jauhiainen, T. Vilkuna-Rautiainen, J. Sundvall, M. Vesanen, K. Mattila, T. Palosuo, G. Alfthan, and S. Asikainen Periodontitis decreases the antiatherogenic potency of high density lipoprotein J. Lipid Res., January 1, 2004; 45(1): 139 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-R. Nofer, R. Feuerborn, B. Levkau, A. Sokoll, U. Seedorf, and G. Assmann Involvement of Cdc42 Signaling in ApoA-I-induced Cholesterol Efflux J. Biol. Chem., December 26, 2003; 278(52): 53055 - 53062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Hillstrom, A. K. Yacapin-Ammons, and S. M. Lynch Vitamin C Inhibits Lipid Oxidation in Human HDL J. Nutr., October 1, 2003; 133(10): 3047 - 3051. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Calabresi, M. Gomaraschi, and G. Franceschini Endothelial Protection by High-Density Lipoproteins: From Bench to Bedside Arterioscler Thromb Vasc Biol, October 1, 2003; 23(10): 1724 - 1731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Soro, M. Jauhiainen, C. Ehnholm, and M.-R. Taskinen Determinants of low HDL levels in familial combined hyperlipidemia J. Lipid Res., August 1, 2003; 44(8): 1536 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lusa, S. Heino, and E. Ikonen Differential Mobilization of Newly Synthesized Cholesterol and Biosynthetic Sterol Precursors from Cells J. Biol. Chem., May 23, 2003; 278(22): 19844 - 19851. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Grewal, I. de Diego, M. F. Kirchhoff, F. Tebar, J. Heeren, F. Rinninger, and C. Enrich High Density Lipoprotein-induced Signaling of the MAPK Pathway Involves Scavenger Receptor Type BI-mediated Activation of Ras J. Biol. Chem., May 2, 2003; 278(19): 16478 - 16481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Heeren, T. Grewal, A. Laatsch, D. Rottke, F. Rinninger, C. Enrich, and U. Beisiegel Recycling of Apoprotein E Is Associated with Cholesterol Efflux and High Density Lipoprotein Internalization J. Biol. Chem., April 11, 2003; 278(16): 14370 - 14378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Mulligan, M. T. Flowers, A. Tebon, J. J. Bitgood, C. Wellington, M. R. Hayden, and A. D. Attie ABCA1 Is Essential for Efficient Basolateral Cholesterol Efflux during the Absorption of Dietary Cholesterol in Chickens J. Biol. Chem., April 4, 2003; 278(15): 13356 - 13366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Marcil, R. Bissonnette, J. Vincent, L. Krimbou, and J. Genest Cellular Phospholipid and Cholesterol Efflux in High-Density Lipoprotein Deficiency Circulation, March 18, 2003; 107(10): 1366 - 1371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Watts, P. H. R. Barrett, J. Ji, A. P. Serone, D. C. Chan, K. D. Croft, F. Loehrer, and A. G. Johnson Differential Regulation of Lipoprotein Kinetics by Atorvastatin and Fenofibrate in Subjects With the Metabolic Syndrome Diabetes, March 1, 2003; 52(3): 803 - 811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Chroni, T. Liu, I. Gorshkova, H.-Y. Kan, Y. Uehara, A. von Eckardstein, and V. I. Zannis The Central Helices of ApoA-I Can Promote ATP-binding Cassette Transporter A1 (ABCA1)-mediated Lipid Efflux. AMINO ACID RESIDUES 220-231 OF THE WILD-TYPE ApoA-I ARE REQUIRED FOR LIPID EFFLUX IN VITRO AND HIGH DENSITY LIPOPROTEIN FORMATION IN VIVO J. Biol. Chem., February 21, 2003; 278(9): 6719 - 6730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hara, T. Matsushima, H. Satoh, N. Iso-o, H. Noto, M. Togo, S. Kimura, Y. Hashimoto, and K. Tsukamoto Isoform-Dependent Cholesterol Efflux From Macrophages by Apolipoprotein E Is Modulated by Cell Surface Proteoglycans Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): 269 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H.E.M. Klerkx, M. W.T. Tanck, J. J.P. Kastelein, H. O.F. Molhuizen, J. W. Jukema, A. H. Zwinderman, and J. A. Kuivenhoven Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629C->A polymorphism and a novel promoter variant are independently associated with CETP concentration Hum. Mol. Genet., January 15, 2003; 12(2): 111 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Gargalovic and L. Dory Caveolins and macrophage lipid metabolism J. Lipid Res., January 1, 2003; 44(1): 11 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. T Yim and P. H Chong Niacin-ER and Lovastatin Treatment of Hypercholesterolemia and Mixed Dyslipidemia Ann. Pharmacother., January 1, 2003; 37(1): 106 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lee, C. P. Sommerhoff, A. von Eckardstein, F. Zettl, H. Fritz, and P. T. Kovanen Mast Cell Tryptase Degrades HDL and Blocks Its Function as an Acceptor of Cellular Cholesterol Arterioscler Thromb Vasc Biol, December 1, 2002; 22(12): 2086 - 2091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. B. Clarkson, M. S. Anthony, T. S. Mikkola, and R. W. St Clair Comparison of Tibolone and Conjugated Equine Estrogens Effects on Carotid Artery Atherosclerosis of Postmenopausal Monkeys Stroke, November 1, 2002; 33(11): 2700 - 2703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Parhami, B. Basseri, J. Hwang, Y. Tintut, and L. L. Demer High-Density Lipoprotein Regulates Calcification of Vascular Cells Circ. Res., October 4, 2002; 91(7): 570 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Jansen, A. J. M. Verhoeven, and E. J. G. Sijbrands Hepatic lipase: a pro- or anti-atherogenic protein? J. Lipid Res., September 1, 2002; 43(9): 1352 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang and B. Paigen Quantitative Trait Loci and Candidate Genes Regulating HDL Cholesterol: A Murine Chromosome Map Arterioscler Thromb Vasc Biol, September 1, 2002; 22(9): 1390 - 1401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Feister, B. J. Auerbach, L. A. Cole, B. R. Krause, and S. K. Karathanasis Identification of an IL-6 response element in the human LCAT promoter J. Lipid Res., June 1, 2002; 43(6): 960 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. B. Javitt 25R,26-Hydroxycholesterol revisited: synthesis, metabolism, and biologic roles J. Lipid Res., May 1, 2002; 43(5): 665 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Van Eck, I. S. T. Bos, W. E. Kaminski, E. Orso, G. Rothe, J. Twisk, A. Bottcher, E. S. Van Amersfoort, T. A. Christiansen-Weber, W.-P. Fung-Leung, et al. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues PNAS, April 30, 2002; 99(9): 6298 - 6303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Levinson High Density- and Beta-Lipoprotein Screening for Risk of Coronary Artery Disease in the Context of New Findings on Reverse Cholesterol Transport Ann. Clin. Lab. Sci., April 1, 2002; 32(2): 123 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Baez, S. E. Barbour, and D. E. Cohen Phosphatidylcholine Transfer Protein Promotes Apolipoprotein A-I-mediated Lipid Efflux in Chinese Hamster Ovary Cells J. Biol. Chem., February 15, 2002; 277(8): 6198 - 6206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Baldassarre, M. Amato, L. Pustina, E. Tremoli, C. R. Sirtori, L. Calabresi, and G. Franceschini Increased Carotid Artery Intima-Media Thickness in Subjects With Primary Hypoalphalipoproteinemia Arterioscler Thromb Vasc Biol, February 1, 2002; 22(2): 317 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Argmann, C. H. Van Den Diepstraten, C. G. Sawyez, J. Y. Edwards, R. A. Hegele, B. M. Wolfe, and M. W. Huff Transforming Growth Factor-{beta}1 Inhibits Macrophage Cholesteryl Ester Accumulation Induced by Native and Oxidized VLDL Remnants Arterioscler Thromb Vasc Biol, December 1, 2001; 21(12): 2011 - 2018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. H. Huang, C.-Y. Lin, J. F. Oram, and T. Mazzone Sterol Efflux Mediated by Endogenous Macrophage ApoE Expression Is Independent of ABCA1 Arterioscler Thromb Vasc Biol, December 1, 2001; 21(12): 2019 - 2025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Williams and F. K. Welty High Level of High-Density Lipoprotein Cholesterol (HDL-C) Does Not Attenuate Increased Risk of Elevated Triglycerides Arch Intern Med, October 22, 2001; 161(19): 2385 - 2385. [Full Text] [PDF]
|
|
|
|
|
|
D. C. McManus, B. R. Scott, V. Franklin, D. L. Sparks, and Y. L. Marcel Proteolytic Degradation and Impaired Secretion of an Apolipoprotein A-I Mutant Associated with Dominantly Inherited Hypoalphalipoproteinemia J. Biol. Chem., June 8, 2001; 276(24): 21292 - 21302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-R. Nofer, B. Levkau, I. Wolinska, R. Junker, M. Fobker, A. von Eckardstein, U. Seedorf, and G. Assmann Suppression of Endothelial Cell Apoptosis by High Density Lipoproteins (HDL) and HDL-associated Lysosphingolipids J. Biol. Chem., September 7, 2001; 276(37): 34480 - 34485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Van Eck, I. S. T. Bos, W. E. Kaminski, E. Orso, G. Rothe, J. Twisk, A. Bottcher, E. S. Van Amersfoort, T. A. Christiansen-Weber, W.-P. Fung-Leung, et al. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues PNAS, April 30, 2002; 99(9): 6298 - 6303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. de Grooth, J. A. Kuivenhoven, A. F.H. Stalenhoef, J. de Graaf, A. H. Zwinderman, J. L. Posma, A. van Tol, and J. J.P. Kastelein Efficacy and Safety of a Novel Cholesteryl Ester Transfer Protein Inhibitor, JTT-705, in Humans: A Randomized Phase II Dose-Response Study Circulation, May 7, 2002; 105(18): 2159 - 2165. [Abstract] [Full Text] [PDF]
|
|